NCT00167934View on ClinicalTrials.gov

Determining Metabolic Effects of Valproate and Antipsychotic Therapy

NACompletedINTERVENTIONAL
Enrollment

164

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Schizophrenia
Interventions
DRUG

Valproate

Depakote ER 500 mg to 3000 mg taken every night

DRUG

Placebo

Placebo given at same frequency as Valproate

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Washington University School of Medicine

OTHER

NCT00167934 - Determining Metabolic Effects of Valproate and Antipsychotic Therapy | Biotech Hunter | Biotech Hunter